Literature DB >> 26051870

Does True Neurocognitive Dysfunction Contribute to Minnesota Multiphasic Personality Inventory-2nd Edition-Restructured Form Cognitive Validity Scale Scores?

Phillip K Martin1, Ryan W Schroeder2, Robin J Heinrichs2, Lyle E Baade2.   

Abstract

Previous research has demonstrated RBS and FBS-r to identify non-credible reporters of cognitive symptoms, but the extent that these scales might be influenced by true neurocognitive dysfunction has not been previously studied. The present study examined the relationship between these cognitive validity scales and neurocognitive performance across seven domains of cognitive functioning, both before and after controlling for PVT status in 120 individuals referred for neuropsychological evaluations. Variance in RBS, but not FBS-r, was significantly accounted for by neurocognitive test performance across most cognitive domains. After controlling for PVT status, however, relationships between neurocognitive test performance and validity scales were no longer significant for RBS, and remained non-significant for FBS-r. Additionally, PVT failure accounted for a significant proportion of the variance in both RBS and FBS-r. Results support both the convergent and discriminant validity of RBS and FBS-r. As neither scale was impacted by true neurocognitive dysfunction, these findings provide further support for the use of RBS and FBS-r in neuropsychological evaluations.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cognitive dysfunction; Malingering; Minnesota Multiphasic Personality Inventory-2nd Edition-Restructured Form; Validity scale

Mesh:

Year:  2015        PMID: 26051870     DOI: 10.1093/arclin/acv032

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  1 in total

1.  Performance validity and symptom validity tests: Are they measuring different constructs?

Authors:  Anna S Ord; Robert D Shura; Ashley R Sansone; Sarah L Martindale; Katherine H Taber; Jared A Rowland
Journal:  Neuropsychology       Date:  2021-04-08       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.